Policy | August 03, 2022
PIB: India imported Rs. 35,249 crore worth APIs and Bulk drugs in 2021-22.
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
He was appointed a Board member and the Chairman in 2012.
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
Govt committed to supporting pharma companies with industry-friendly policies
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Subscribe To Our Newsletter & Stay Updated
